Re: Cytokine Storm & Vitamin D relationship?
Tropical,
If you wish to read it, our critique of Lappe's work is here:
http://mpkb.mp-dev.com/doku.php/home:pathogenesis:vitamind:cancer
Dr. Woodson,
You get a lot of it right.
"As I understand the thesis, there are numerous micro-organisms that live within our cells. There is a long list of these provided in the papers and presentations on Dr. Marshall's web site. Virtually all those named are not ones I recognize as common human pathogens. Is this correct?"
The volume and diversity of bacteria in the human body must be appreciated. According to a recent National Institutes of Health (NIH) estimate, 90% of cells in the human body are bacterial, fungal, or otherwise non-human. Your salivary microbiome has 500+ species of bacteria. Hip joints have been shown to contain hydrothermal vent eubacteria, which have previously been shown to exist only in underwater heat vents. That said, we don't put much stock in species. We would point to the work of Doolittle and others, who has argued we believe that our traditional understanding of "species" is outmoded. Bacteria exchange DNA so promiscuously that it is often hard to define what constitutes a bacterial species. Read more here:
http://mpkb.mp-dev.com/doku.php/home:pathogenesis:microbiota
"The thesis goes on to state that these intracellular [intra not inter - I changed the other instances of this word in your other comments] non-human organisms produce substances, ligands, that affect the VDR in a way that results in its inability to function normally. Is this correct? This impairment of the VDR by these bacterial substances is the proximal cause of a variety of human diseases including several common auto-immune diseases. Is this correct?"
Yes, that's what we're putting forth. Although we might put HIV and EBV in this category given that they have also been shown to downregulate the Vitamin D Receptor (VDR).
"The Marshall Protocol is a treatment for this condition that uses very low dose antibiotics used in sequence and in combination beginning with minocycline [sp], then azithromycin [sp] and clindamycin [sp] that is designed to kill the intracellular bacteria slowly. This is beneficial since killing them rapidly could or does result in an exacerbation of the manifest disease do to contamination of the human cell interior with high levels of dead and degenerating bacterial organisms. Is this correct?"
We have found that pulsed low dosing is the only way to address these treatment-resistant microbes. The rationale for this approach is here:
http://mpkb.mp-dev.com/doku.php/home:protocol:mp_antibiotics:dosing
The only thing I would add to this comment is that the only way to kill these chronic pathogens is slowly. We know now other way to kill these chronic (as opposed to acute pathogens). Killing bacteria generates a self-limiting reaction we refer to as immunopathology. Immunopathology involves the release of cytokines and the bioavailability of endotoxins. Read more here:
http://mpkb.mp-dev.com/doku.php/home:protocol:immunopathology
"Some intracellular bacteria are beneficial while others are pathologic to the human host cell. Is this correct?"
As far as we're concerned, that remains to be seen. One reason I could give you for questioning the friendliness/benefit of any single bacteria is horizontal gene transfer, a common occurrence in which microbes swap DNA:
http://mpkb.mp-dev.com/doku.php/home:pathogenesis:horizontal_gene
HGT is so prolific that it is rather easy for friendly strains to pick up pathogenic characteristics. Another point I'd like to make is that we try to look at disease through the lens of immunopathology. If you give a person a substance such as vitamin D or a bolus of bacteria such as a probiotics supplement and the person's symptoms improve, why did those symptoms improve? We would argue that it's because few intracellular and other bacteria are being eradicated. In the case of probiotics, we would say that, at best, the supplements distract the immune response from fighting the intracellular pathogens. If you look at end-stage patients who are given probiotics, those supplements actually increase morbidity:
http://mpkb.mp-dev.com/doku.php/home:othertreatments:probiotics
"Once the intracellular bacteria are cleared from the cell, then the VDR is freed from the pathologic affects of their ligands and becomes free to return to its normal function. Is this correct? Freeing the VDR of the pathologic influence of the intracellular bacteria results in remission and ultimately cure of the autoimmune disease caused by the infection. Is this correct?"
Yes.
"The Marshall Protocol includes the administration of Bencar to patients treated with it because this ARB, approved by the US FDA for treatment of high blood pressure has the interesting property of occupying the VDR as an antagonist. This therefore provides the patient undergoing the Marshall Protocol with the benefits of VDR stimulation without resort to use of vitamin D3 supplements that leads to formation of 25 OH vit D3 which the thesis proposes results in feedback down regulation of the VDR, an event that exacerbates the underlying disorder. Is this correct?"
That's right. Among the ARBs, Benicar alone activates the VDR. In fact, there wold be no Marshall Protocol without Benicar. You can give the same pulsed low-dose antibiotics to a patient without Benicar and you do not get the tell-tale bacterial die-off reaction (which as you read previously, is called immunopathology). We have discovered that patients needs regular (3-4 times daily) doses of Benicar to knock the ligands off the VDR.
Best,
Paul
Tropical,
If you wish to read it, our critique of Lappe's work is here:
http://mpkb.mp-dev.com/doku.php/home:pathogenesis:vitamind:cancer
Dr. Woodson,
You get a lot of it right.
"As I understand the thesis, there are numerous micro-organisms that live within our cells. There is a long list of these provided in the papers and presentations on Dr. Marshall's web site. Virtually all those named are not ones I recognize as common human pathogens. Is this correct?"
The volume and diversity of bacteria in the human body must be appreciated. According to a recent National Institutes of Health (NIH) estimate, 90% of cells in the human body are bacterial, fungal, or otherwise non-human. Your salivary microbiome has 500+ species of bacteria. Hip joints have been shown to contain hydrothermal vent eubacteria, which have previously been shown to exist only in underwater heat vents. That said, we don't put much stock in species. We would point to the work of Doolittle and others, who has argued we believe that our traditional understanding of "species" is outmoded. Bacteria exchange DNA so promiscuously that it is often hard to define what constitutes a bacterial species. Read more here:
http://mpkb.mp-dev.com/doku.php/home:pathogenesis:microbiota
"The thesis goes on to state that these intracellular [intra not inter - I changed the other instances of this word in your other comments] non-human organisms produce substances, ligands, that affect the VDR in a way that results in its inability to function normally. Is this correct? This impairment of the VDR by these bacterial substances is the proximal cause of a variety of human diseases including several common auto-immune diseases. Is this correct?"
Yes, that's what we're putting forth. Although we might put HIV and EBV in this category given that they have also been shown to downregulate the Vitamin D Receptor (VDR).
"The Marshall Protocol is a treatment for this condition that uses very low dose antibiotics used in sequence and in combination beginning with minocycline [sp], then azithromycin [sp] and clindamycin [sp] that is designed to kill the intracellular bacteria slowly. This is beneficial since killing them rapidly could or does result in an exacerbation of the manifest disease do to contamination of the human cell interior with high levels of dead and degenerating bacterial organisms. Is this correct?"
We have found that pulsed low dosing is the only way to address these treatment-resistant microbes. The rationale for this approach is here:
http://mpkb.mp-dev.com/doku.php/home:protocol:mp_antibiotics:dosing
The only thing I would add to this comment is that the only way to kill these chronic pathogens is slowly. We know now other way to kill these chronic (as opposed to acute pathogens). Killing bacteria generates a self-limiting reaction we refer to as immunopathology. Immunopathology involves the release of cytokines and the bioavailability of endotoxins. Read more here:
http://mpkb.mp-dev.com/doku.php/home:protocol:immunopathology
"Some intracellular bacteria are beneficial while others are pathologic to the human host cell. Is this correct?"
As far as we're concerned, that remains to be seen. One reason I could give you for questioning the friendliness/benefit of any single bacteria is horizontal gene transfer, a common occurrence in which microbes swap DNA:
http://mpkb.mp-dev.com/doku.php/home:pathogenesis:horizontal_gene
HGT is so prolific that it is rather easy for friendly strains to pick up pathogenic characteristics. Another point I'd like to make is that we try to look at disease through the lens of immunopathology. If you give a person a substance such as vitamin D or a bolus of bacteria such as a probiotics supplement and the person's symptoms improve, why did those symptoms improve? We would argue that it's because few intracellular and other bacteria are being eradicated. In the case of probiotics, we would say that, at best, the supplements distract the immune response from fighting the intracellular pathogens. If you look at end-stage patients who are given probiotics, those supplements actually increase morbidity:
http://mpkb.mp-dev.com/doku.php/home:othertreatments:probiotics
"Once the intracellular bacteria are cleared from the cell, then the VDR is freed from the pathologic affects of their ligands and becomes free to return to its normal function. Is this correct? Freeing the VDR of the pathologic influence of the intracellular bacteria results in remission and ultimately cure of the autoimmune disease caused by the infection. Is this correct?"
Yes.
"The Marshall Protocol includes the administration of Bencar to patients treated with it because this ARB, approved by the US FDA for treatment of high blood pressure has the interesting property of occupying the VDR as an antagonist. This therefore provides the patient undergoing the Marshall Protocol with the benefits of VDR stimulation without resort to use of vitamin D3 supplements that leads to formation of 25 OH vit D3 which the thesis proposes results in feedback down regulation of the VDR, an event that exacerbates the underlying disorder. Is this correct?"
That's right. Among the ARBs, Benicar alone activates the VDR. In fact, there wold be no Marshall Protocol without Benicar. You can give the same pulsed low-dose antibiotics to a patient without Benicar and you do not get the tell-tale bacterial die-off reaction (which as you read previously, is called immunopathology). We have discovered that patients needs regular (3-4 times daily) doses of Benicar to knock the ligands off the VDR.
Best,
Paul